Medical therapy for Cushing's disease

Endocrinology and Metabolism Clinics of North America

Volumn 28, Issue 1, 1999, Pages 211-222

  Sonino, N ^a   Boscaro, M ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; AMINOGLUTETHIMIDE; BROMOCRIPTINE; CYPROHEPTADINE; DOPAMINE RECEPTOR STIMULATING AGENT; KETOCONAZOLE; METYRAPONE; MIFEPRISTONE; MITOTANE; OCTREOTIDE; RITANSERIN; SEROTONIN ANTAGONIST; SOMATOSTATIN DERIVATIVE; VALPROIC ACID;

ADRENAL GLAND; CORTICOTROPIN RELEASE; CUSHING DISEASE; DISEASE CLASSIFICATION; DOSE RESPONSE; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; NEUROMODULATION; PRIORITY JOURNAL; REVIEW; STEROIDOGENESIS; TREATMENT PLANNING;

EID: 0032934435     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(05)70064-5     Document Type: Article

References (69)

1. J.S. Adams O.P. Sharma M.M. Diz Ketoconazole decreases the serum 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia J Clin Endocrinol Metab 70 1990 1090 1095
2. F. Awonters C.J.E. Niemegeers A.A.H.P. Megens Pharmacological profile of ritanserin Drug Develop Res 15 1988 61 73
3. E.E. Baulieu The steroid hormone antagonist RU 486 Endocrinol Metab Clin North Am 20 1991 873 891
4. A. Beckers A. Stevenert G. Pirens Cyclic Cushing's disease and its successful control under sodium valproate J Endocrinol Invest 13 1990 923 925
5. R. Benecke E. Keller B. Vetter Plasma level monitoring of mitotane (o,p'DDD) and its metabolite (o,p'DDE) during long-term treatment of Cushing's disease with low doses Eur J Clin Pharmacol 41 1991 259 261
6. X. Bertagna C. Bertagna Ladat M.-H. Pituitary-adrenal response to the antiglucocorticoid action of RU 486 in Cushing's syndrome J Clin Endocrinol Metab 63 1986 639 643
7. Blevins L.S. Jr J.H. Christy M. Khajavi Outcomes of therapy for Cushing's disease due to adrenocorticotropin-secreting pituitary macroadenomas J Clin Endocrinol Metab 83 1998 63 67
8. D. Bochicchio M. Losa M. Buchfelder Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: A retrospective study by the European Cushing's Disease Survey Group J Clin Endocrinol Metab 80 1995 3114 3120
9. M. Boscaro M. Benato F. Mantero Effect of bromocriptine in pituitary-dependent Cushing's syndrome Clin Endocrinol 19 1983 485 491
10. M. Boscaro N. Sonino Cushing's disease: Medical treatment Landolt A.M. Vance M.L. Reilly P.L. Pituitary Adenomas 1996 Churchill Livingstone London 417 430
11. A. Colao R. Pivonello F.S. Tripodi Failure of long-term therapy with sodium valproate in Cushing's disease J Endocrinol Invest 20 1997 387 392
12. M.J. Connell J. Cordiner D.L. Davies Pregnancy complicated by Cushing's syndrome: Potential hazard of metyrapone therapy. Case report Br J Obstet Gynaecol 92 1985 1192 1195
13. D.M. Cook J.W. Kendall J.P. Allen Nyctohemeral variation and suppressibility of plasma ACTH in various stages of Cushing's disease Clinical Endocrinology 5 1976 303 314
14. B. Couzinet P. Thomopoulos G. Schaison Durable remission of Cushing's disease after o, p′ = DDD treatment Acta Endocrinologica 100 1982 63 67
15. R.J.M. Croughs H.P.F. Koppeschaar Van't Verlaat J.W. Bromocriptine-responsive Cushing's disease associated with anterior pituitary corticotroph hyperplasia or normal pituitary gland J Clin Endocrinol Metab 68 1989 495 498
16. de Herder W.W. S.W.J. Lamberts Is there a role for somatostatin and its analogs in Cushing's syndrome? Metabolism 45 1996 83 85
17. G. Dickstein A. Spindel C. Schechner Spontaneous remission in Cushing's disease Arch Intern Med 151 1991 185 189
18. J. Donckier J.M. Burrin D.I. Ramsay Successful control of Cushing's disease in the elderly with long-term metyrapone Postgrad Med J 62 1986 727 730
19. J. Estrada M. Boronat M. Mielgo The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease N Engl J Med 336 1997 172 177
20. L.M. Fishman G.W. Liddle D.P. Island Effects of aminogluthetimide on adrenal function in man J Clin Endocrinol Metab 27 1967 481 490
21. A.R. Glass C. Eil Ketoconazole induced reduction in serum 1,25-dihydroxyvitamin D and total serum calcium in hypercalcemic patients J Clin Endocrinol Metab 66 1988 934 938
22. M. Gomi S. Iida Y. Itoh Unaltered stimulation of pituitary adrenocorticotrophin secretion by corticotrophin-releasing factor following sodium valproate administration in a patient with Nelson's syndrome Clin Endocrinol 23 1985 123 127
23. D.N. Griffith E.J. Ross Pregnancy after cyproheptadine treatment for Cushing's disease N Engl J Med 305 1981 893 895
24. H. Gylling H. Vanhanen T.A. Miettinen Hypolipidemic effect and mechanism of ketoconazole without and with cholestyramine in familial hypercholesterolemia Metabolism 4 1991 35 41
25. W.J. Jeffcoate L.H. Rees S. Tomplin Metyrapone in long-term management of Cushing's disease BMJ 2 1977 215 217
26. T.E. Knight C.Y. Shikuma J. Knight Ketoconazole-induced fulminant hepatitis necessitating liver transplantation J Am Acad Dermatol 25 1991 398 400
27. H.P.F. Koppeschaar R.J.M. Croughs J.H.H. Thijssen Sodium valproate and cyproheptadine may independently induce a remission in the same patients with Cushing's disease Acta Endocrinol 104 1983 160 163
28. H.P.F. Koppeschaar R.J.M. Croughs J.H.H. Thijssen Response to neurotransmitter modulating drugs in patients with Cushing's disease Clin Endocrinol 2 1986 661 667
29. D.T. Krieger Physiopathology of Cushing's disease Endocr Rev 4 1983 22 43
30. D.T. Krieger M. Luria Effectiveness of cyproheptadine in decreasing plasma ACTH concentrations in Nelson's syndrome J Clin Endocrinol Metab 43 1976 1179 1182
31. G. Lake-Bakaar P.J. Scheuer S. Scherlock Hepatic reactions associated with ketoconazole in the United Kingdom BMJ 294 1987 419 422
32. Lamberts S.W.J. de Lange S.A. S.Z. Stefanko Adrenocorticotropin-secreting pituitary adenomas originate from the anterior or the intermediate lobe in Cushing's disease: Differences in the regulation of hormone secretion J Clin Endocrinol Metab 54 1982 286 291
33. S.W.J. Lamberts H.A. Timmermans De Jong F.H. The role of dopaminergic depletion in the pathogenesis of Cushing's disease and the possible consequences of medical therapy Clin Endocrinol 7 1977 185 193
34. Lamberts S.W.J. van der Lely A.J. de Herder W.W. Transsphenoidal selective adenomectomy is the treatment of choice in patients with Cushing's disease: Considerations concerning preoperative medical treatment and the long-term follow up J Clin Endocrinol Metab 80 1995 3111 3113
35. J.P. Luton J.A. Mahoudeau P.H. Bouchard Treatment of Cushing's disease by o,p'-DDD: Survey of 62 cases N Engl J Med 300 1979 459 464
36. V.M.G. Maher P.J. Trainer A. Scoppola Possible mechanisms and treatment of o,p'DDD-induced hypercholesterolemia Q J Med 84 1992 671 679
37. D.R. Mc Cance D.R. Hadden L. Kennedy Clinical experience with ketoconazole as a therapy for patients with Cushing's syndrome Clin Endocrinol 27 1987 593 599
38. L.B. Mercado-Asis K. Yasuda M. Murayama Beneficial effects of high daily dose bromocriptine in Cushing's disease Endocrinol Jpn 39 1992 385 395
39. T.A. Miettinen Cholesterol metabolism during ketoconazole treatment in man J Lipid Res 29 1988 43 51
40. J.W. Miller L. Crapo The medical treatment of Cushing's syndrome Endocr Rev 14 1993 443 458
41. S.S. Nussey P. Price J.S. Jenkins The combined use of sodium valproate and metyrapone in the treatment of Cushing's syndrome Clin Endocrinol 28 1988 373 380
42. M.L. Rallison L.F. Kumagar F.H. Tyler Goitrous hypothyroidism induced by aminoglutethimide, anticonvulsive drug J Clin Endocrinol Metab 27 1967 265 272
43. W.M. Ross D.C. Evered P. Hunter Treatment of Cushing's disease with adrenal blocking drugs and megavoltage therapy to the pituitary Clin Radiol 30 1979 149 153
44. O. Sartor G.B. Cutler Mefiprestone: Treatment of Cushing's syndrome Clin Obstet Gynecol 39 1996 506 510
45. D.E. Schteingart H.S. Tsao C.I. Taylor Sustained remission in Cushing's disease with mitotane and pituitary irradiation Ann Intern Med 92 1980 613 619
46. M.A. Shaw P.J. Nicholls H.J. Smith Aminoglutethimide and ketoconazole: Historical perspective and future prospects J Steroid Biochem 31 1988 137 146
47. N. Sonino The use of ketoconazole as an inhibitor of steroid production N Engl J Med 317 1987 812 818
48. N. Sonino From the lesson of Harvey Cushing's to current knowledge: Psychosocial aspects of endocrine disease Psychother Psychosom 66 1997 113 116
49. N. Sonino M. Boscaro G. Ambroso Prolonged treatment of Cushing's disease with metyrapone and aminoglutethimide IRCS Med Sci 14 1986 485 486
50. N. Sonino M. Boscaro F. Fallo Potential therapeutic effects of ritanserin in Cushing's disease JAMA 267 1992 1073
51. N. Sonino M. Boscaro G. Merola Prolonged treatment of Cushing's disease by ketoconazole J Clin Endocrinol Metab 61 1985 718 722
52. N. Sonino M. Boscaro A. Paoletta Ketoconazole treatment in Cushing's syndrome: Experience in 34 patients Clin Endocrinol 35 1991 347 352
53. N. Sonino F. Fallo M. Boscaro Ketoconazole and other inhibitors of steroid production: Current use Med Sci Res 17 1989 131 134
54. N. Sonino G.A. Fava Serotonin, Cushing's disease and depression Psychother Psychosom 65 1996 63 65
55. N. Sonino G.A. Fava Psychosomatic aspects of Cushing's disease Psychother Psychosom 67 1998 140 146
56. N. Sonino G.A. Fava M. Boscaro A role for life events in the pathogenesis of Cushing's disease Clin Endocrinol 38 1993 261 264
57. N. Sonino M. Zielezny G.A. Fava Risk factors and long-term outcome in pituitary-dependent Cushing's disease J Clin Endocrinol Metab 81 1996 2647 2652
58. Stricker BHCh A.P.R. Blok F.B. Bronkhorst Ketoconazole-associated hepatic injury J Hepatol 3 1986 399 406
59. T. Suda F. Tozawa T. Mouri Effects of cyproheptadine, reserpine, and synthetic corticotropin-releasing factor on pituitary gland from patients with Cushing's disease J Clin Endocrinol Metab 56 1983 1094 1099
60. R. Tanakol F. Alagöl H. Azizlerli Cyproheptadine treatment in Cushing's disease J Endocrinol Invest 19 1996 242 247
61. Thoren M. Adamson U. H.E. Sjöberg Aminoglutethimide and metyrapone in the management of Cushing's syndrome Acta Endocrinol 109 1985 451 457
62. R.D. Utiger Treatment, and retreatment, of Cushing's disease N Engl J Med 336 1997 172 177
63. van Seters A.P. A.J. Moolenaar Mitotane increases the blood levels of hormone-binding proteins Acta Endocrinol 124 1991 526 533
64. van Waveren Hogervorst C.O. H.P.F. Koppeschaar P.M.J. Zelissen Cortisol secretory patterns in Cushing's disease and response to cyproheptadine treatment J Clin Endocrinol Metab 81 1996 652 655
65. J.A. Verhelst P.J. Trainer T.A. Howlett Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome Clin Endocrinol 35 1991 169 178
66. F. Vignati P. Loli Additive effect of ketoconazole and octreotide in the treatment of severe adrenocorticotropin-dependent hypercortisolism J Clin Endocrinol Metab 81 1996 2885 2890
67. C. Wallace E.L. Toth R.Z. Lewanczuk Pregnancy-induced Cushing's syndrome in multiple pregnancies J Clin Endocrinol Metab 81 1996 15 21
68. H.M. Whitehead R. Beacom B. Sheridan The effect of cyproheptadine and/or bromocriptine on plasma ACTH levels in patients cured of Cushing's disease by bilateral adrenalectomy Clin Endocrinol 32 1990 193 202
69. M. Zachmann R.P. Gitzelmann M. Zagalak Effect of aminoglutethimide on urinary cortisol and cortisol metabolites in adolescents with Cushing's syndrome Clin Endocrinol 7 1977 63 71